Effect of SCF and IFN-γ, IL-4, or IL-5 on human mast cells after 8 weeks of culture
After 8-wk culture . | SCF . | SCF + IFN-γ . | SCF + IL-4 . | SCF + IL-5 . |
---|---|---|---|---|
No. cells | 13.2 ± 2.1 × 106 | 0.4 ± 0.23 × 106 | 2.0 ± 0.2 × 106 | 7.2 ± 0.8 × 106 |
No. mast cells | 12.4 ± 3.1 × 106 | 0 | 1.8 ± 0.5 × 106 | 6.2 ± 0.7 × 106 |
Total divisions | 19 | 15 | 14 | 17 |
CD34 expression MFI | 11.2 ± 2.3 | 11.5 ± 2.1 | 12.3 ± 2.5 | 11.3 ± 3.1 |
Kit expression MFI | 665.8 ± 89.9 | 22.9 ± 5.3 | 10.0 ± 3.4 | 653 ± 92.8 |
FcγRI expression % positive | 70.7 | 0.4 | 30.4 | 59.2 |
β-hex release % of total | 27.8 ± 3.5 | 3.3 ± 1.3 | 12.6 ± 2.5 | 30.0 ± 2.1 |
Tryptase content pg/cell | 11.3 ± 2.3 | 1.2 ± 0.2 | 5.8 ± 0.4 | 19.3 ± 1.6 |
Histamine content pg/cell | 4.3 ± 0.6 | 0.6 ± 0.1 | 3.5 ± 0.5 | 3.1 ± 1.4 |
Morphology | Toluidine positive many granules | Toluidine negative few granules | Toluidine positive some granules | Toluidine positive many granules |
Size (diameter) | 10-12 μm | 3-5 μm | 5-7 μm | 10-12 μm |
After 8-wk culture . | SCF . | SCF + IFN-γ . | SCF + IL-4 . | SCF + IL-5 . |
---|---|---|---|---|
No. cells | 13.2 ± 2.1 × 106 | 0.4 ± 0.23 × 106 | 2.0 ± 0.2 × 106 | 7.2 ± 0.8 × 106 |
No. mast cells | 12.4 ± 3.1 × 106 | 0 | 1.8 ± 0.5 × 106 | 6.2 ± 0.7 × 106 |
Total divisions | 19 | 15 | 14 | 17 |
CD34 expression MFI | 11.2 ± 2.3 | 11.5 ± 2.1 | 12.3 ± 2.5 | 11.3 ± 3.1 |
Kit expression MFI | 665.8 ± 89.9 | 22.9 ± 5.3 | 10.0 ± 3.4 | 653 ± 92.8 |
FcγRI expression % positive | 70.7 | 0.4 | 30.4 | 59.2 |
β-hex release % of total | 27.8 ± 3.5 | 3.3 ± 1.3 | 12.6 ± 2.5 | 30.0 ± 2.1 |
Tryptase content pg/cell | 11.3 ± 2.3 | 1.2 ± 0.2 | 5.8 ± 0.4 | 19.3 ± 1.6 |
Histamine content pg/cell | 4.3 ± 0.6 | 0.6 ± 0.1 | 3.5 ± 0.5 | 3.1 ± 1.4 |
Morphology | Toluidine positive many granules | Toluidine negative few granules | Toluidine positive some granules | Toluidine positive many granules |
Size (diameter) | 10-12 μm | 3-5 μm | 5-7 μm | 10-12 μm |
Data presented are mean ± SEM (n = 5).